Clinical Trial Update: A Study of Remimazolam Tosilate for Sedation in the ICU [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing remimazolam tosilate for ICU sedation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation in the Intensive Care Unit

Drugs mentioned

• Remimazolam Tosilate (remimazolam)

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Sedation in the ICU | Phase 2 | Status: COMPLETED